Ampicillin
Ampicillin is a broad-spectrum, semisynthetic penicillin-class antibiotic used to treat susceptible bacterial infections, including certain respiratory tract infections, urinary tract infections, gastrointestinal infections, and infections caused by organisms such as Listeria monocytogenes and susceptible enterococci. It works by inhibiting bacterial cell-wall synthesis, leading to bacterial cell death. Ampicillin is available in oral and injectable formulations, with the route and dosage determined by the type and severity of infection, the patient’s clinical condition, and bacterial susceptibility. It may be used in hospital settings for serious infections, including selected cases of meningitis and bloodstream infections, when clinically appropriate. Common adverse effects include nausea, diarrhoea, and skin rash; serious risks include allergic reactions and antibiotic-associated colitis. Ampicillin should be used under medical supervision, with caution in patients with penicillin allergy or impaired kidney function, and only when the suspected or confirmed bacteria are susceptible to treatment.
Ampicillin was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Ampicillin, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Ampicillin from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Ampicillin, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
